APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Tuberculosis (TB) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global BCG Tuberculosis (TB) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025182 pages

Choose your research edition.

Industry ResearchBCG Tuberculosis (TB) Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Tuberculosis (TB) Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal BCG Tuberculosis (TB) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Tuberculosis (TB) Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global BCG Tuberculosis (TB) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of BCG Tuberculosis (TB) Vaccine include China National Biotec, Sanofi Pasteur, Merck, Serum Institute of India, Japan BCG Lab, Intervax and GSBPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global BCG Tuberculosis (TB) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of BCG Tuberculosis (TB) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BCG Tuberculosis (TB) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the BCG Tuberculosis (TB) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

BCG Tuberculosis (TB) Vaccine Segment by Company

China National Biotec

Sanofi Pasteur

Merck

Serum Institute of India

Japan BCG Lab

Intervax

GSBPL

BCG Tuberculosis (TB) Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Tuberculosis (TB) Vaccine Segment by Application

Hospital

Clinic

BCG Tuberculosis (TB) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Tuberculosis (TB) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Tuberculosis (TB) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Tuberculosis (TB) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the BCG Tuberculosis (TB) Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. BCG Tuberculosis (TB) Vaccine Industry Trends Table 2. BCG Tuberculosis (TB) Vaccine Industry Drivers Table 3. BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges Table 4. BCG Tuberculosis (TB) Vaccine Industry Restraints Table 5. Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Manufacturers Table 9. Global BCG Tuberculosis (TB) Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global BCG Tuberculosis (TB) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global BCG Tuberculosis (TB) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global BCG Tuberculosis (TB) Vaccine Manufacturers, Product Type & Application Table 13. Global BCG Tuberculosis (TB) Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global BCG Tuberculosis (TB) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Immune BCG Table 17. Major Manufacturers of Therapy BCG Table 18. Global BCG Tuberculosis (TB) Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2026) Table 22. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2027-2032) Table 23. Global BCG Tuberculosis (TB) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global BCG Tuberculosis (TB) Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2026) Table 34. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2027-2032) Table 35. Global BCG Tuberculosis (TB) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2021-2026) Table 43. Global BCG Tuberculosis (TB) Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global BCG Tuberculosis (TB) Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global BCG Tuberculosis (TB) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2027-2032) Table 62. China National Biotec Company Information Table 63. China National Biotec Business Overview Table 64. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio Table 66. China National Biotec Recent Development Table 67. Sanofi Pasteur Company Information Table 68. Sanofi Pasteur Business Overview Table 69. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio Table 71. Sanofi Pasteur Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck BCG Tuberculosis (TB) Vaccine Product Portfolio Table 76. Merck Recent Development Table 77. Serum Institute of India Company Information Table 78. Serum Institute of India Business Overview Table 79. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio Table 81. Serum Institute of India Recent Development Table 82. Japan BCG Lab Company Information Table 83. Japan BCG Lab Business Overview Table 84. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio Table 86. Japan BCG Lab Recent Development Table 87. Intervax Company Information Table 88. Intervax Business Overview Table 89. Intervax BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio Table 91. Intervax Recent Development Table 92. GSBPL Company Information Table 93. GSBPL Business Overview Table 94. GSBPL BCG Tuberculosis (TB) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio Table 96. GSBPL Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. BCG Tuberculosis (TB) Vaccine Distributors List Table 100. BCG Tuberculosis (TB) Vaccine Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. BCG Tuberculosis (TB) Vaccine Product Image Figure 2. Global BCG Tuberculosis (TB) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Tuberculosis (TB) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global BCG Tuberculosis (TB) Vaccine Sales (2021-2032) & (k units) Figure 5. Global BCG Tuberculosis (TB) Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 BCG Tuberculosis (TB) Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Immune BCG Image Figure 9. Therapy BCG Image Figure 10. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global BCG Tuberculosis (TB) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global BCG Tuberculosis (TB) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2032) Figure 38. China BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile BCG Tuberculosis (TB) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global BCG Tuberculosis (TB) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. BCG Tuberculosis (TB) Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. BCG Tuberculosis (TB) Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospital
  • Clinic
Companies covered
  • China National Biotec
  • Sanofi Pasteur
  • Merck
  • Serum Institute of India
  • Japan BCG Lab
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global BCG Tuberculosis (TB) Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global BCG Tuberculosis (TB) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global BCG Tuberculosis (TB) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global BCG Tuberculosis (TB) Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global BCG Tuberculosis (TB) Vaccine Market Dynamics
  1. 2.1 BCG Tuberculosis (TB) Vaccine Industry Trends
  2. 2.2 BCG Tuberculosis (TB) Vaccine Industry Drivers
  3. 2.3 BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Tuberculosis (TB) Vaccine Industry Restraints
3 BCG Tuberculosis (TB) Vaccine Market by Manufacturers
  1. 3.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global BCG Tuberculosis (TB) Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global BCG Tuberculosis (TB) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global BCG Tuberculosis (TB) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global BCG Tuberculosis (TB) Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global BCG Tuberculosis (TB) Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global BCG Tuberculosis (TB) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 BCG Tuberculosis (TB) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 BCG Tuberculosis (TB) Vaccine Tier 1, Tier 2, and Tier 3
4 BCG Tuberculosis (TB) Vaccine Market by Type
  1. 4.1 BCG Tuberculosis (TB) Vaccine Type Introduction
  2. 4.1.1 Immune BCG
  3. 4.1.2 Therapy BCG
  4. 4.2 Global BCG Tuberculosis (TB) Vaccine Sales by Type
  5. 4.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global BCG Tuberculosis (TB) Vaccine Revenue by Type
  9. 4.3.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2032)
5 BCG Tuberculosis (TB) Vaccine Market by Application
  1. 5.1 BCG Tuberculosis (TB) Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global BCG Tuberculosis (TB) Vaccine Sales by Application
  5. 5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global BCG Tuberculosis (TB) Vaccine Revenue by Application
  9. 5.3.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2032)
6 Global BCG Tuberculosis (TB) Vaccine Sales by Region
  1. 6.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global BCG Tuberculosis (TB) Vaccine Revenue by Region
  1. 7.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Region
  2. 7.1.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America BCG Tuberculosis (TB) Vaccine Revenue (2021-2032)
  8. 7.2.2 North America BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe BCG Tuberculosis (TB) Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 China National Biotec
  2. 8.1.1 China National Biotec Company Information
  3. 8.1.2 China National Biotec Business Overview
  4. 8.1.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio
  6. 8.1.5 China National Biotec Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 Japan BCG Lab
  26. 8.5.1 Japan BCG Lab Company Information
  27. 8.5.2 Japan BCG Lab Business Overview
  28. 8.5.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio
  30. 8.5.5 Japan BCG Lab Recent Developments
  31. 8.6 Intervax
  32. 8.6.1 Intervax Company Information
  33. 8.6.2 Intervax Business Overview
  34. 8.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio
  36. 8.6.5 Intervax Recent Developments
  37. 8.7 GSBPL
  38. 8.7.1 GSBPL Company Information
  39. 8.7.2 GSBPL Business Overview
  40. 8.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio
  42. 8.7.5 GSBPL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 BCG Tuberculosis (TB) Vaccine Value Chain Analysis
  2. 9.1.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 BCG Tuberculosis (TB) Vaccine Production Mode & Process
  6. 9.2 BCG Tuberculosis (TB) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 BCG Tuberculosis (TB) Vaccine Distributors
  9. 9.2.3 BCG Tuberculosis (TB) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst